These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 270872)

  • 1. [Conservative treatment of ulcerative colitis and Crohn's disease with chemically defined diets].
    Peters H
    Z Ernahrungswiss Suppl; 1977; (20):58-64. PubMed ID: 270872
    [No Abstract]   [Full Text] [Related]  

  • 2. [Parenteral-peroral combined treatement of Crohn's disease and ulcerative colitis].
    Peters H
    Infusionsther Klin Ernahr; 1976 Aug; 3(4):222-6. PubMed ID: 821860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of parenteral and elementary enteral nutrition in the treatment of Crohn's disease and ulcerative colitis in children].
    Ricour C; Duhamel JF; Nihoul-Fekete C
    Arch Fr Pediatr; 1977; 34(6):505-13. PubMed ID: 410386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C; Backmerhoff F; Schumacher B; Niederau C
    Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis.
    Letizia C; Boirivant M; De Toma G; Cerci S; Subioli S; Scuro L; Ferrari P; Pallone F
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):266-9. PubMed ID: 9759593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nutritional problems in diseases of the small and large intestine].
    Base W; Ferenci P; Pesendorfer FX; Aigner O; Wewalka F
    Infusionsther Klin Ernahr; 1976 Feb; 3(1):6-10. PubMed ID: 1254326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The disease activity of ulcerative colitis and Crohn's disease.
    Talstad I; Gjone E
    Scand J Gastroenterol; 1976; 11(4):403-8. PubMed ID: 935802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long term feeding with a chemically defined diet].
    Erlangen CB
    Infusionsther Klin Ernahr Sonderh; 1975; 3():4-6. PubMed ID: 1184191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitis.
    Rhodes JM; Potter BJ; Brown DJ; Jewell DP
    Gastroenterology; 1982 Jun; 82(6):1327-34. PubMed ID: 6978274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The usefulness of reactive protein C in managing patients with ulcerative colitis and Crohn's disease].
    López Morante AJ; Sáez-Royuela F; Yuguero del Moral L; Martín Lorente JL; Ojeda Giménez C
    Rev Esp Enferm Dig; 1993 Jan; 83(1):5-9. PubMed ID: 8452705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a prodromal period in Crohn's disease but not ulcerative colitis.
    Pimentel M; Chang M; Chow EJ; Tabibzadeh S; Kirit-Kiriak V; Targan SR; Lin HC
    Am J Gastroenterol; 2000 Dec; 95(12):3458-62. PubMed ID: 11151877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
    Folwaczny C; Wiebecke B; Loeschke K
    Am J Gastroenterol; 1999 Jun; 94(6):1551-5. PubMed ID: 10364024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commonalities in the time trends of Crohn's disease and ulcerative colitis.
    Delcò F; Sonnenberg A
    Am J Gastroenterol; 1999 Aug; 94(8):2171-6. PubMed ID: 10445545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on blood coagulation in ulcerative colitis and Crohn's disease].
    Mori K; Hiwatashi N; Suzuki S; Sugai K; Hisa S; Sakai H; Watanabe H; Endo K; Miura T
    Rinsho Ketsueki; 1982 Oct; 23(10):1540-8. PubMed ID: 7154258
    [No Abstract]   [Full Text] [Related]  

  • 16. Some serum protein studies in Crohn's disease and ulcerative colitis.
    Sandor G; Levy E; Malafosse M; Huguet C; Huguier M; Loygue J
    Res Commun Chem Pathol Pharmacol; 1975 May; 11(1):129-45. PubMed ID: 1153856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic and therapeutic implications of allergic processes in Crohn's disease and ulcerative colitis (author's transl)].
    Tschaikowski KL; Jorde W
    Leber Magen Darm; 1979 Dec; 9(6):294-8. PubMed ID: 547140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum mucoproteins in patients with nonspecific ulcerative colitis and Crohn's disease].
    Levitan MKh; Dovgun LM; Ilysheva GN; Chernomordik AE; Ksenofontov BS
    Sov Med; 1980; (7):19-22. PubMed ID: 7256382
    [No Abstract]   [Full Text] [Related]  

  • 19. Coagulation studies in ulcerative colitis and Crohn's disease.
    Lam A; Borda IT; Inwood MJ; Thomson S
    Gastroenterology; 1975 Feb; 68(2):245-51. PubMed ID: 1116673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: Abnormalities of splenic function in ulcerative colitis and Crohn's disease.
    Ryan FP; Preston FE; Smart RC; Holdsworth CD
    Gut; 1975 Oct; 16(10):834. PubMed ID: 1205306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.